These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17917114)

  • 1. TWEAK and the central nervous system.
    Yepes M
    Mol Neurobiol; 2007 Jun; 35(3):255-65. PubMed ID: 17917114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-like weak inducer of apoptosis increases the permeability of the neurovascular unit through nuclear factor-kappa B pathway activation.
    Polavarapu R; Gongora MC; Winkles JA; Yepes M
    J Neurosci; 2005 Nov; 25(44):10094-100. PubMed ID: 16267216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of TWEAK activity as a new treatment for inflammatory and degenerative diseases.
    Yepes M; Winkles JA
    Drug News Perspect; 2006 Dec; 19(10):589-95. PubMed ID: 17299600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
    Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
    J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tweak and FN14 in central nervous system health and disease.
    Yepes M
    Front Biosci; 2007 May; 12():2772-81. PubMed ID: 17485258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The tumor necrosis factor-like weak inducer of apoptosis (TWEAK)-fibroblast growth factor-inducible 14 (Fn14) signaling system regulates glioma cell survival via NFkappaB pathway activation and BCL-XL/BCL-W expression.
    Tran NL; McDonough WS; Savitch BA; Sawyer TF; Winkles JA; Berens ME
    J Biol Chem; 2005 Feb; 280(5):3483-92. PubMed ID: 15611130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A further TWEAK to multiple sclerosis pathophysiology.
    Nazeri A; Heydarpour P; Sadaghiani S; Sahraian MA; Burkly LC; Bar-Or A
    Mol Neurobiol; 2014 Feb; 49(1):78-87. PubMed ID: 23873135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TWEAK/Fn14 promotes pro-inflammatory cytokine secretion in hepatic stellate cells via NF-κB/STAT3 pathways.
    Wang A; Zhang F; Xu H; Xu M; Cao Y; Wang C; Xu Y; Su M; Zhang M; Zhuge Y
    Mol Immunol; 2017 Jul; 87():67-75. PubMed ID: 28411440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 mediate cerebral ischemia-induced poly(ADP-ribose) polymerase-1 activation and neuronal death.
    Haile WB; Echeverry R; Wu F; Guzman J; An J; Wu J; Yepes M
    Neuroscience; 2010 Dec; 171(4):1256-64. PubMed ID: 20955770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The interaction between tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 promotes the recruitment of neutrophils into the ischemic brain.
    Haile WB; Echeverry R; Wu J; Yepes M
    J Cereb Blood Flow Metab; 2010 Jun; 30(6):1147-56. PubMed ID: 20068578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of TWEAK and its receptor Fn14 in the multiple sclerosis brain: implications for inflammatory tissue injury.
    Serafini B; Magliozzi R; Rosicarelli B; Reynolds R; Zheng TS; Aloisi F
    J Neuropathol Exp Neurol; 2008 Dec; 67(12):1137-48. PubMed ID: 19018248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A soluble Fn14-Fc decoy receptor reduces infarct volume in a murine model of cerebral ischemia.
    Yepes M; Brown SA; Moore EG; Smith EP; Lawrence DA; Winkles JA
    Am J Pathol; 2005 Feb; 166(2):511-20. PubMed ID: 15681834
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytokine tumor necrosis factor-like weak inducer of apoptosis and its receptor fibroblast growth factor-inducible 14 have a neuroprotective effect in the central nervous system.
    Echeverry R; Wu F; Haile WB; Wu J; Yepes M
    J Neuroinflammation; 2012 Mar; 9():45. PubMed ID: 22394384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibroblast growth factor inducible (Fn14)-specific antibodies concomitantly display signaling pathway-specific agonistic and antagonistic activity.
    Salzmann S; Seher A; Trebing J; Weisenberger D; Rosenthal A; Siegmund D; Wajant H
    J Biol Chem; 2013 May; 288(19):13455-66. PubMed ID: 23532848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TWEAK-independent Fn14 self-association and NF-κB activation is mediated by the C-terminal region of the Fn14 cytoplasmic domain.
    Brown SA; Cheng E; Williams MS; Winkles JA
    PLoS One; 2013; 8(6):e65248. PubMed ID: 23750247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TWEAK mediates signal transduction and differentiation of RAW264.7 cells in the absence of Fn14/TweakR. Evidence for a second TWEAK receptor.
    Polek TC; Talpaz M; Darnay BG; Spivak-Kroizman T
    J Biol Chem; 2003 Aug; 278(34):32317-23. PubMed ID: 12794080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor necrosis factor-like weak inducer of apoptosis-induced neurodegeneration.
    Potrovita I; Zhang W; Burkly L; Hahm K; Lincecum J; Wang MZ; Maurer MH; Rossner M; Schneider A; Schwaninger M
    J Neurosci; 2004 Sep; 24(38):8237-44. PubMed ID: 15385607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells.
    Roos A; Dhruv HD; Mathews IT; Inge LJ; Tuncali S; Hartman LK; Chow D; Millard N; Yin HH; Kloss J; Loftus JC; Winkles JA; Berens ME; Tran NL
    Oncotarget; 2017 Feb; 8(7):12234-12246. PubMed ID: 28103571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TWEAK/Fn14 activation induces keratinocyte proliferation under psoriatic inflammation.
    Cheng H; Xu M; Liu X; Zou X; Zhan N; Xia Y
    Exp Dermatol; 2016 Jan; 25(1):32-7. PubMed ID: 26264384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TWEAK/Fn14 pathway modulates properties of a human microvascular endothelial cell model of blood brain barrier.
    Stephan D; Sbai O; Wen J; Couraud PO; Putterman C; Khrestchatisky M; Desplat-Jégo S
    J Neuroinflammation; 2013 Jan; 10():9. PubMed ID: 23320797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.